Baltimore , MD 21201 Location map
2016 PDA Biosimilars Conference
The 2016 PDA Biosimilars Conference will bring together all levels of industry professionals to network and benefit from a program that will provide an update on recent regulatory expectations for the approval of biosimilars. The Conference will bring together industry experts and regulators to review and discuss new development strategies for biosimilars. Successful case studies will be presented to illustrate how analytical similarity can be demonstrated and practical control strategies (process validation and specifications) can be developed. Attendees can expect to receive current updates from the regulatory agencies, about which CMC aspects have been most challenging for the CMC reviewer, and will have the opportunity to raise questions and concerns during the Conference.
There may be many networking opportunities at the 2016 PDA Biosimilars Conference. Find out more in the event details below.
Parenteral Drug Association (PDA)
4350 East-West Highway
Bethesda, MD 20814
VPs | Directors | Heads | Managers | Senior Scientists
Professionals with immediate to advance knowledge and experience in the following:
Biotechnology| Bioanalytics | Biomanufacturing | Biopharmaceuticals | Bioprocessing| Biosimilars | Biotherapeutics | Cell Line | Clinical Immunology | Development | Commercial Biologics | Drug Safety & Risk Management | Expression Systems | Immunogenicity Testing | Market Entry | Partnering and Licensing | Patient Safety | Product Development | Protein Characterization | Scale-up Processes | Quality Assurance | Regulatory Affairs | Regulatory CMC
Exhibitor Information +